These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

561 related articles for article (PubMed ID: 27014640)

  • 41. Stealth Strategies of
    Naeem MA; Ahmad W; Tyagi R; Akram Q; Younus M; Liu X
    Curr Issues Mol Biol; 2021; 41():597-616. PubMed ID: 33068079
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nucleomodulin BspJ as an effector promotes the colonization of
    Ma Z; Yu S; Cheng K; Miao Y; Xu Y; Hu R; Zheng W; Yi J; Zhang H; Li R; Li Z; Wang Y; Chen C
    J Vet Sci; 2022 Jan; 23(1):e8. PubMed ID: 34841746
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Role for the VPS Retromer in
    Casanova A; Low SH; Québatte M; Sedzicki J; Tschon T; Ketterer M; Smith K; Emmenlauer M; Ben-Tekaya H; Dehio C
    mSphere; 2019 Jun; 4(3):. PubMed ID: 31243080
    [No Abstract]   [Full Text] [Related]  

  • 44. Active evasion of CTL mediated killing and low quality responding CD8+ T cells contribute to persistence of brucellosis.
    Durward M; Radhakrishnan G; Harms J; Bareiss C; Magnani D; Splitter GA
    PLoS One; 2012; 7(4):e34925. PubMed ID: 22558103
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In situ microscopy analysis reveals local innate immune response developed around Brucella infected cells in resistant and susceptible mice.
    Copin R; Vitry MA; Hanot Mambres D; Machelart A; De Trez C; Vanderwinden JM; Magez S; Akira S; Ryffel B; Carlier Y; Letesson JJ; Muraille E
    PLoS Pathog; 2012; 8(3):e1002575. PubMed ID: 22479178
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pathogenesis of
    Yu J; Li S; Wang L; Dong Z; Si L; Bao L; Wu L
    Crit Rev Microbiol; 2022 Feb; 48(1):96-120. PubMed ID: 34214000
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Brucella abortus uses a stealthy strategy to avoid activation of the innate immune system during the onset of infection.
    Barquero-Calvo E; Chaves-Olarte E; Weiss DS; Guzmán-Verri C; Chacón-Díaz C; Rucavado A; Moriyón I; Moreno E
    PLoS One; 2007 Jul; 2(7):e631. PubMed ID: 17637846
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Brucella suppress STING expression via miR-24 to enhance infection.
    Khan M; Harms JS; Liu Y; Eickhoff J; Tan JW; Hu T; Cai F; Guimaraes E; Oliveira SC; Dahl R; Cheng Y; Gutman D; Barber GN; Splitter GA; Smith JA
    PLoS Pathog; 2020 Oct; 16(10):e1009020. PubMed ID: 33108406
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Chemical Genetics Screen Reveals Influence of p38 Mitogen-Activated Protein Kinase and Autophagy on Phagosome Development and Intracellular Replication of Brucella neotomae in Macrophages.
    Kang YS; Kirby JE
    Infect Immun; 2019 Aug; 87(8):. PubMed ID: 31160361
    [No Abstract]   [Full Text] [Related]  

  • 50. The changing nature of the Brucella-containing vacuole.
    Celli J
    Cell Microbiol; 2015 Jul; 17(7):951-8. PubMed ID: 25916795
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunopathology of Brucella infection.
    Baldi PC; Giambartolomei GH
    Recent Pat Antiinfect Drug Discov; 2013 Apr; 8(1):18-26. PubMed ID: 22812614
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Avoidance and Subversion of Eukaryotic Homeostatic Autophagy Mechanisms by Bacterial Pathogens.
    Miller C; Celli J
    J Mol Biol; 2016 Aug; 428(17):3387-98. PubMed ID: 27456933
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Brucellosis and type IV secretion.
    de Jong MF; Tsolis RM
    Future Microbiol; 2012 Jan; 7(1):47-58. PubMed ID: 22191446
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Brucellosis: a worldwide zoonosis.
    Boschiroli ML; Foulongne V; O'Callaghan D
    Curr Opin Microbiol; 2001 Feb; 4(1):58-64. PubMed ID: 11173035
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The peculiar ways of Brucella survival: looking through the keyhole.
    Pappas G
    Virulence; 2010; 1(6):473-4. PubMed ID: 21178493
    [No Abstract]   [Full Text] [Related]  

  • 56. 5-Lipoxygenase negatively regulates Th1 response during Brucella abortus infection in mice.
    Fahel JS; de Souza MB; Gomes MT; Corsetti PP; Carvalho NB; Marinho FA; de Almeida LA; Caliari MV; Machado FS; Oliveira SC
    Infect Immun; 2015 Mar; 83(3):1210-6. PubMed ID: 25583526
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A Brucella Type IV Effector Targets the COG Tethering Complex to Remodel Host Secretory Traffic and Promote Intracellular Replication.
    Miller CN; Smith EP; Cundiff JA; Knodler LA; Bailey Blackburn J; Lupashin V; Celli J
    Cell Host Microbe; 2017 Sep; 22(3):317-329.e7. PubMed ID: 28844886
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The role of innate immune receptors in the control of Brucella abortus infection: toll-like receptors and beyond.
    Oliveira SC; de Oliveira FS; Macedo GC; de Almeida LA; Carvalho NB
    Microbes Infect; 2008 Jul; 10(9):1005-9. PubMed ID: 18664388
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of antigen presentation by Brucella: many more than many ways.
    Barrionuevo P; Giambartolomei GH
    Microbes Infect; 2019; 21(3-4):136-142. PubMed ID: 30677519
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Brucella: a Mr "Hide" converted into Dr Jekyll.
    Gorvel JP
    Microbes Infect; 2008 Jul; 10(9):1010-3. PubMed ID: 18664389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.